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Abstract: 
Micellar liquid chromatography (MLC) is a popular method used in the determination of a 
compounds lipophilicity. This study describes the use of the obtained micelle/water partition 
coefficient (log Pmw) by such a method in the prediction of human intestinal absorption 
(HIA). As a result of the close resemblance of the novel composition of the micellar mobile 
phase to that of physiological intestinal fluid, prediction was deemed to be highly successful. 
The unique micellar mobile phase consisted of a mixed micellar mixture of lecithin and six 
bile salts, i.e. a composition matching that found in the human intestinal environment, 
prepared in ratios resembling those in the intestine. This is considered to be the first method 
to use a physiological mixture of biosurfactants in the prediction of HIA. As a result, a 
mathematical model with high predictive ability (R
2
PRED= 81 %) was obtained using multiple 
linear regression. The micelle/water partition coefficient (log Pmw) obtained from MLC was 
found to be a successful tool for prediction where the final optimum model included (log 
Pmw) and polar surface area (PSA) as key descriptors with high statistical significance for the 
prediction of HIA. This can be attributed to the nature of the mobile phase used in this study 
which contains the lecithin-bile salt complex, thus forming a bilayer system therefore 
mimicking absorption across the intestinal membrane.  
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Introduction: 
The oral route is considered to be the most popular route of administration for pharmaceutical 
entities. However, the properties of such compounds must be suited to delivery via this route 
(Arlington, 2000; Kennedy, 1997; Prentis, Lis, & Walker, 1988; Venkatesh & Lipper, 2000). 
Early identification of drug candidates with poor biopharmaceutical properties, such as poor 
aqueous solubility and oral bioavailability, is advantageous to avoid potential economic loss 
on subsequent unsuccessful clinical research. As a result, there has been a growing interest in 
the early prediction of biopharmaceutical properties by means of experimental and theoretical 
models. 
Drug solubility and permeation are the two main properties that affect drug absorption from 
the intestinal lumen (Amidon, Lennernäs, Shah, & Crison, 1995; Johnson & Swindell, 1996; 
Norris, Leesman, Sinko, & Grass, 2000). Once identified, drugs with poor solubility have a 
greater possibility for improvement when compared with those with low intestinal 
permeability as drug solubility can be enhanced by choosing a more suitable formulation 
option. As a consequence of this, focussed synthesis of compounds with structures of 
reasonably high permeability during the early stages of drug development is preferential. 
Since drug lipophilicity is considered a key descriptor that dictates permeation across 
biological membranes (Rutkowska, PajIk, & Jóźwiak, 2012), the evaluation or determination 
of the lipophilicity of a drug is important for its characterisation to ensure its potential to 
penetrate lipid barriers and subsequently be absorbed (Lipinski, Lombardo, Dominy, & 
Feeney, 2001; Scott & Clymer, 2002). Therefore, determining the lipophilicity of a 
compound can help in the prediction of human intestinal absorption (HIA).  
Having the ability to explore the effects of micelles on the behaviour of a compound, micellar 
liquid chromatography (MLC) has been developed over the past 30 years to yield information 
on a wide variety of compounds where a surfactant aqueous solution is used above its critical 
micellar concentration (cmc) (Berthod & Garcia-Alvarez-Coque, 2000) (Ruiz‐Ángel, 
García‐Álvarez‐Coque, & Berthod, 2009). A very important physicochemical property 
indicating lipophilicity, log Pmw, can be obtained using MLC in the presence of different 
surfactants as the micellar mobile phase to help characterise compounds (Kawczak et al., 
2010; Marina & Garcia, 2000). For example, MLC has been used with a simple surfactant 
solution in previously published work for the prediction of HIA for a series of compounds 
using multiple linear regression analysis (Waters, Shokry, & Parkes, 2016). The novelty of 
the work presented in this study lies in the use of a very unique mobile phase mimicking the 
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in vivo intestinal environment of humans. The composition of this mobile phase was closely 
related to that of the intestinal fluid through a combination of lecithin and bile salts which are 
normally found in the human intestine, used in ratios matching those found physiologically 
(Wiedmann, Liang, & Kamel, 2002). 
Methods and Materials: 
Sodium deoxycholate (NaDC) (97 %), sodium taurodeoxycholate (NaTDC) (95 %), sodium 
taurocholate (NaTC) (≥ 97 %), sodium cholate (NaC) (97 %), sodium glycocholate (GC) (≥ 
97 %), sodium glycodeoxycholate (GDC) (≥ 97 %) and L-α-phosphatidylcholine from dried 
egg yolk (≥ 50 %) were used as purchased from Sigma Aldrich, Dorset, UK for the 
preparation of stock solutions of mobile phase. Analytical grade 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES buffer) was purchased from Sigma Aldrich, Dorset, 
UK. The compounds considered in this work were caffeine 97 % (Sigma Aldrich, Dorset, 
UK), fenoprofen 97 % (Fluka, Dorset, UK), acetaminophen 99 % (Sigma Aldrich, Dorset, 
UK), ketoprofen 98 % (Sigma Aldrich, Dorset, UK), phenylbutazone 99 % (Sigma Aldrich, 
Dorset, UK), fluconazole 98 % (Sigma Aldrich, Dorset, UK), carbamazepine 99 % (Sigma 
Aldrich, Dorset, UK), cimetidine (Sigma Aldrich, Dorset, UK), naproxen 98 % (Sigma 
Aldrich, Dorset, UK), terbutaline 96 % (Sigma Aldrich, Dorset, UK), zolmitriptan >98 % 
(Sigma Aldrich, Dorset, UK), salicylic acid 99 % (Fisher Scientific, Loughborough, UK), 
ibuprofen 98 % (BASF, Cheshire, UK), acetyl salicylic acid 99 % (Acros Organics, Geel, 
Belgium), diclofenac 98 % (TCI Europe, Zwijndrecht, Belgium), flurbiprofen 98 % (TCI 
Europe), nicotinic acid >98 % (Sigma Aldrich, Dorset, UK) and theophylline 98 %, (TCI, 
Oxford, UK). 
Preparation of stock solution of micellar mixture simulating the physiological bile salt 
mixture 
17 mM stock solution of a mixed micellar system was prepared by transferring accurately 
weighed amounts equivalent to 2.71 mM, 2.00 mM, 2.08 mM, 2.08 mM, 4.70 mM and 3.43 
mM of NaTC, NaTDC, NaDC, NaC, NaGC and NaGDC bile salts respectively and 0.75 mM 
of egg phosphatidylcholine (PC) to a 250 mL volumetric flask with buffer solution (10 mM 
HEPES, pH = 6.5) in 0.15 M NaCl. The solution was then sonicated for 30 minutes and 
stored for 12 hours before use to allow the formation of stable mixed micelles. 
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Preparation of a mixed micellar solution for dilution  
Different concentrations of the micellar mixture were prepared over the range of (5-17 mM) 
by diluting the stock solution using a 2 mM mixture solution. The 2 mM mixture solution 
contained the same six bile salts and lecithin used in the preparation of the stock mixture 
solution in the same molar ratios. The 2 mM diluting mixture was prepared by transferring 
accurately weighed amounts equivalent to 0.32 mM, 0.25 mM, 0.24 mM, 0.24 mM, 0.55 
mM, 0.4 mM of NaTC, NaTDC, NaDC, NaC, NaGC and NaGDC bile salts respectively and 
0.75 mM of egg phosphatidylcholine (PC) to a 250 mL volumetric flask with buffer as 
detailed previously. The resultant solution was sonicated for 30 minutes then stored for 12 
hours before use. Dilution was carried out in this way as the 2 mM mixture is considered to 
be the monomer bile salt concentration that is required to be kept constant in each solution in 
order to keep the size of the micelle constant while its concentration is being changed 
(Wiedmann et al., 2002).  
Analytical instrumentation and measurement 
Experiments were carried out with a chromatographic system consisting of an Agilent 1100 
series binary pump, a Rheodyne injector through which 20 μL samples were injected in to the 
system and a UV detector (Perseptive Biosystems UVIS-205), set at a wavelength 
appropriate for each drug producing a peak via Picolog software indicating the retention of 
the solute within the column as a function of time. The mobile phase was filtered through a 
0.45 µm Nylon filter and degassed in an ultrasonic bath. Data were recorded and then 
analysed to obtain retention factors and each run was repeated three times to ensure that 
reasonable accuracy and precision were achieved. Analytical separation was accomplished 
using a reversed phase cyanopropyl column (Spherisorb 5 μm, 15 cm × 4.6 mm i.d., 
WATERS). The flow rate used was 1.34 mL/min with all assays carried out at 37 ºC. The 
mobile phase was placed in a water bath at 37 ºC throughout the duration of all experiments. 
Determination of dead time t0 
The dead time (t0) is defined as the time taken by the solvent front to reach the detector, 
measured by the injection of water (Pramauro, Minero, Saini, Graglia, & Pelizzetti, 1988) or 
an organic solvent e.g. acetonitrile or methanol (Khaledi, 1988; Khaledi, Peuler, & Ngeh-
Ngwainbi, 1987). In this work, dead time was determined by injecting distilled water or 
acetonitrile in to the system and recording the retention time of the first peak that appeared 
after injection (solvent front). The same method was repeated for each of the bile salt 
concentrations used. A reliable value of dead time used in the calculation of retention factor 
  
This article is protected by copyright. All rights reserved. 
(k’) for all experiments (using Equation 1) was determined from an average of at least ten 
recordings. 
 
Calculation of log Pmw 
 
Retention behaviour of binding solutes as a function of the micellar concentration [M] 
(concentration of surfactant monomers forming micelles equal to total surfactant 
concentration minus the CMC) has been explained by many proposed theoretical approaches 
such as the Armstrong & Nome partitioning model, the Arunyanarat & Cline-Love model and 
the Foley model 
(Armstrong & Nome, 1981; Arunyanart & Love, 1984; Garcia-Alvarez-Coque, Torres-
Lapasió, & Baeza-Baeza, 1997). 
From the obtained chromatograms, the retention time of each drug was recorded for each bile 
salt concentration (Figure 1). The retention factor for each retention time was calculated 
using the following equation: 
   
                           
         
           Eq. (1) 
The reciprocal of each retention factor was obtained (1/  ) with the average value plotted 
against the micellar concentration (CM) that was calculated according to the following 
equation: 
                                                                           Eq. (2) 
The partition coefficient (log Pmw) was obtained from the slope and intercept of the line 
obtained from the plot of (CM) against (1/  ). 
                                          Eq. (3) 
Results 
Mixed micellar system 
Since bile salts and lecithin (phosphatidylcholine) are considered to be two of the most 
common biosurfactants present in bile and involved in the digestion process, it was important 
to study the effect of using a mixed micellar system consisting of six bile salts and lecithin 
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phospholipid as a mobile phase in MLC. The mixed micellar system used in this method 
consisted of a mixture of six bile salts (NaDC, NaC, NaTDC, NaTC, NaGC and NaGDC) 
which included dihydroxy, trihydroxy, conjugated and unconjugated bile salts with lecithin 
phospholipid in 0.15 M NaCl with the pH controlled by HEPES buffer at 6.5. The CMC of 
the mixed micellar system was deemed to be 0.0046 M based on the average value of the 
CMCs of the bile salts included in the mixture in 0.15 M NaCl (NaTC CMC =0.004 M 
(Natalini et al., 2014), NaDC CMC =0.0024 M (Natalini et al., 2014), NaTDC CMC =0.0024 
M (Natalini et al., 2014), NaC CMC =0.0075 M (Reis et al., 2004), NaGC CMC =0.009 M 
(Natalini et al., 2014) and NaGDC CMC =0.0022 M (Natalini et al., 2014)). The bile salt-
lecithin mixed micellar solution was used over a concentration range of (0.005-0.017 M). The 
mixed micellar system was prepared in molar ratios similar to that present physiologically 
(Wiedmann et al., 2002).   
Having both a positively charged choline head group and a negatively charged phosphate 
group, lecithin is considered to be a zwitterionic compound that tends to self-assemble in 
water forming characteristic bilayer membrane-like structures (Cheng, Oh, Wang, Raghavan, 
& Tung, 2014). Bile salts are distinguishable from conventional amphiphiles by their facial 
structure with polar and nonpolar faces. Such uniqueness is what leads to the unusual micelle 
structures formed upon bile salts’ self-assembly in water which further separates them from 
conventional head and tail surfactants. Various models have been proposed for bile salt 
micelle formation and several hypotheses have been made regarding their aggregates’ 
structures formed through hydrophobic interactions between the steroid nuclei of bile salts 
(nonpolar face) and the hydrogen bonding between the bile salts hydroxyl groups (polar face) 
(Malik, 2016). It was reported in previous studies that short, rod like micelles were formed 
upon combining both bile salts and lecithin in a mixture (Cheng et al., 2014). The lecithin-
bile salt complex is considered as a balanced system where the lecithin on its own in water 
forms unstable bilayer structures of low aqueous solubility because of its bulky hydrophobic 
tails inhibiting its solubility in water that is compensated and balanced by the presence of the 
bile salts of much greater water solubility. These can, in small amounts, stabilise the lecithin 
self-assembled structures by intercalating into these structures and thus promoting their water 
solubility which is one of the main physiological applications of bile salts. 
Initially, it was suggested by Mazer, Benedek and Carey that the aqueous lecithin/bile salt 
micelles were disc-like in shape (Mazer, Benedek, & Carey, 1980) but later on, different 
techniques provided evidence that these micelles are cylindrical in shape that can further 
grow into long flexible cylindrical micellar chains termed “worms” (Madenci, Salonen, 
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Schurtenberger, Pedersen, & Egelhaaf, 2011; Walter, Vinson, Kaplun, & Talmon, 1991) 
which are similar to polymer chains where they entangle in a transient network rendering the 
solution highly viscous (Dreiss, 2007; Schurtenberger, Scartazzini, & Luisi, 1989; 
Shchipunov, 2001). This transformation of short cylinders to worms depends on the molar 
ratio of the two species and the ionic strength where an almost equimolar ratio of bile salt: 
lecithin (with high background counterion concentration) would induce the growth of the 
cylindrical micelles to worms (Cheng et al., 2014). As a result, caution was taken to avoid the 
formation of a highly viscous solution since the prepared micellar mixture was to be pumped 
through the chromatographic system. For this reason, the bile salt-lecithin mixed micellar 
system was prepared in a molar ratio much higher than one while using an optimum 
counterion concentration (0.15 M NaCl). 
Lecithin prefers to be present in the form of low curvature cylindrical shaped bodies owing to 
its two tails. It is expected the bile salts will stabilise the hemispherical end caps of these 
cylinders as bile salts are generally present in water as highly curved small micelles. Since 
stable end caps prevent the formed cylindrical micelles from further growing into long 
chains, adding more bile salts will result in more end caps being formed and therefore shorter 
cylinders (Cheng et al., 2014). Figure 2 summarises the mechanism of micellisation in the 
bile salt-lecithin mixed micellar system where lecithin prefers to form bilayers when alone in 
water (left side of the figure). On the other hand, when bile salts are added to the solution 
they bind to lecithin head groups (Cheng et al., 2014) with themselves binding back-to-back 
(Coello, Meijide, Núñez, & Tato, 1996) to each other resulting in expansion of the head 
group area (right side of the figure) (Cheng et al., 2014; Madenci et al., 2011). As a result, 
bilayers turn into cylinders where the net geometry changes from a cylinder to truncated 
cone. In the case of low ionic strength, the negatively charged groups of bile salts suffer from 
high repulsion forces therefore bile salts get packed at the curved hemispherical end caps of 
the cylinders. The presence of a counterion (NaCl) of an optimum concentration is important 
because it decreases or neutralises the surface charge on the micelle thereby diminishing 
electrostatic repulsion and encouraging interaction between micelle forming species and 
hydrophobic association of bile salts and lecithin to give mixed micelles. It has to be taken 
into consideration that upon increasing the concentration of counterion, the electrostatic 
repulsion between the bile salts decreases, therefore the aggregation number of bile salt 
micelles increase and bile salts become less likely to form the highly curved end caps of the 
cylindrical mixed micelles inducing the growth of cylinders in to long chains which increase 
the viscosity of solution.  
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Retention behaviour 
Ideally when using an anionic surfactant and a cyanopropyl column, neutral and cationic 
drugs are expected to show a binding interaction as a result of entrapment of drug in the 
hydrophobic core of the micelles (for neutral drugs) or electrostatic attraction (for cationic 
drugs) or both which leads to the decrease in the retention times of these drugs with the 
increase in the mobile phase micellar concentration. On the other hand, anionic drugs are 
expected to show an antibinding interaction due to electrostatic repulsion between the anionic 
drug molecules and the anionic micelles which leads to binding of these drug molecules to 
the cyanopropyl column increasing their retention times with the increase in the micellar 
concentration in the mobile phase(Armstrong & Stine, 1983; Ruiz-Angel, Carda-Broch, 
Torres-Lapasió, & García-Álvarez-Coque, 2009).  
However, all the drug molecules in this study (neutral, cationic and anionic) show a binding 
behaviour reflecting the preference of the analysed drugs to the bile salt-lecithin mixed 
micelles of more stability, bigger hydrophobic core diameter and core fluidity (de Castro, 
Gameiro, Guimarães, Lima, & Reis, 2001). The binding of anionic drug molecules to these 
mixed micelles could be attributed to diminished repulsion forces between the micelles 
resulting from charge neutralisation brought about by counterion (NaCl) binding. Therefore, 
overcoming any remaining weak repulsion forces and not repelling away from the micelles, 
i.e. solubilising within the hydrophobic core of the mixed micelles. 
Statistical Modelling of Human Intestinal absorption (HIA): 
Following analysis of a group of 18 model drugs using a physiologically simulating bile salt-
lecithin mixed micellar solution, followed by calculation of log Pmw from the calibration plots 
of (1/  ) against (CM),  the obtained log Pmw with a number of other molecular descriptors 
such as molecular weight (Mwt), polar surface area (PSA), freely rotating bonds (FRB), 
molar volume (VM), dissociation constant (pKa), aqueous solubility (Sw), number of hydrogen 
bond donors (nHD) and number of hydrogen bond acceptors (nHA) were used for developing 
a model for prediction of percentage human intestinal absorption  (%HIA). Experimentally 
obtained log Pmw values (using this MLC method) with polar surface area (PSA) as the 
selected molecular descriptor included in the final model are shown in Table 1.  
For improving the linear relationship found between reported (%HIA) and experimental log 
Pmw values, logit(HIA) was used as reported in similar studies (Norinder, Österberg, & 
Artursson, 1999; Raevsky, Fetisov, Trepalina, McFarland, & Schaper, 2000; Zhao et al., 
2002). As a result, transformation of human intestinal absorption values to logit was carried 
out by substituting in Equation (4), where %HIA = %Human Intestinal Absorption. 
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Logit (%HIA) = log (%HIA / (100 - %HIA))          Eq. (4)       
Removal of three drugs with % HIA values of 100 or 0 % from the training set was essential. 
Minitab 17® was used in statistical analysis of data. Data was analysed using multiple linear 
regression where all the previously mentioned molecular descriptors (data not shown) were 
included and regressed against the dependant variable %HIA and backward elimination 
modelling strategy was used. As a result, polar surface area (PSA) along with log Pmw were 
the only descriptors included in the final developed model. Variables with high variance 
inflation factors (VIF) were removed for (VIF) to be within the acceptable limits. Finally, an 
optimum model was obtained that provided a good summary of data. Assessment of the 
variables remaining in the final model for significance and relative importance was carried 
out using standardised coefficients and the associated p-values. 
The final model predictive ability was evaluated using adjusted-R
2
 and R
2
 for prediction 
(R
2
PRED) which is able to indicate the predictive ability of the model and consequently 
reflecting the capability for applying the model.  
 
Log Pmw was included in a model equation with %HIA experimental values for orally 
administered drugs which allowed the prediction of human intestinal absorption (%HIA). The 
model obtained for the prediction of %HIA is given by Equation 5: 
logit HIA = 4.103 – 0.939 log Pmw - 0.02218 PSA    Eq. (5) 
Fifteen drugs were used in the development of the final model where log Pmw alongside the 
molecular descriptor (PSA) were included. The model’s R2 = 86.40 %, R2 adjust.= 84.13 % , 
R
2
PRED = 80.73 %, S= 0.247 
A 95 % confidence interval for log Pmw is given by (-1.18, -0.699), t-statistic and standardised 
coefficient of log Pmw are -8.51 (p<0.05) and -0.964 respectively suggesting statistical 
significance of log Pmw as a predictor. Also the F-ratio of the overall model is statistically 
significant, F=38.12 and P value 0.007 (p<0.05). Figure 3 shows no marked relationship 
between residuals and predicted values while Figure 4 summarises the model. The literature 
and predicted values of %HIA are shown in Table 2 and Figure 5. Three drugs 
(acetaminophen, ibuprofen and salicylic acid) were used to test the obtained model. The 
model was able to predict the %HIA for these compounds within a minimum of 0.61 % and a 
maximum of 4.43 % difference between predicted and published data for %HIA. The 
statistical model developed from this study using a bile salts-lecithin physiological mixture 
confirms an enhanced capability for prediction of human intestinal absorption (HIA), with an  
R
2
PRED of 81 %, compared with a previous study using simple micelles of one bile salt 
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(R
2
PRED of 75%) (Waters et al., 2016). The current model involves less predictors (log Pmw 
and polar surface area) than those in the previous model (logPmw, molecular weight and 
solubility) which simplifies the model. Based on previous research, polar surface area has 
been reported to be a successful parameter in the prediction of intestinal absorption (Clark, 
1999; Palm, Stenberg, Luthman, & Artursson, 1997; Stenberg et al., 1999) Furthermore, drug 
absorption relevant information has been shown to be sufficiently encoded in lipophilicity, 
along with polar surface area, without explicit reference to molecular weight (Egan, Merz, & 
Baldwin, 2000). These findings further corroborate that the current model displays 
superiority over the previously developed one for predicting intestinal absorption. 
 
Conclusion: 
Developing an MLC method that used a physiologically resembling bile salt-lecithin mixed 
micellar system was successful for the prediction of human intestinal absorption (HIA). This 
method had a significant impact on the elution of compounds and the type of interaction 
they experienced upon being injected into the MLC system. The bile salt/phospholipid 
combination had a higher solubilising capacity for compounds than that of the individual 
bile salt systems used before (Waters et al., 2016), confirmed by the behaviour of all 
compounds into binding solutes favouring the formed micelles. This developed MLC method 
has a higher predictive ability for HIA (R2PRED= 81 %) compared with previous models. 
Overall, it can be concluded that there is a close resemblance between the ‘physiologically 
occurring’ and ‘synthetic bile salt/phospholipid micellar mixture’ used in this MLC method. 
This helped the compounds to behave in a manner closer to how they permeate through 
the human intestine therefore simulating the human intestinal absorption process to some 
extent and ultimately leading to the construction of a mathematical model with a high 
predictive ability for HIA. 
  
  
This article is protected by copyright. All rights reserved. 
References 
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995). A theoretical basis for a 
biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and 
in vivo bioavailability. Pharmaceutical research, 12(3), 413-420.  
Arlington, S. (2000). Pharma 2005-An industrial revolution in R&D. Pharmaceutical Executive, 20(1), 
74-85.  
Armstrong, D. W., & Nome, F. (1981). Partitioning behavior of solutes eluted with micellar mobile 
phases in liquid chromatography. Analytical chemistry, 53(11), 1662-1666.  
Armstrong, D. W., & Stine, G. Y. (1983). Selectivity in pseudophase liquid chromatography. Analytical 
chemistry, 55(14), 2317-2320.  
Arunyanart, M., & Love, L. C. (1984). Model for micellar effects on liquid chromatography capacity 
factors and for determination of micelle-solute equilibrium constants. Analytical chemistry, 
56(9), 1557-1561.  
Berthod, A., & Garcia-Alvarez-Coque, C. (2000). Micellar liquid chromatography: CRC Press. 
Castillo-Garit, J., Cañizares-Carmenate, Y., Marrero-Ponce, Y., Abad, C., & Torrens, F. (2014). 
Prediction of ADME properties, Part 1: Classification models to predict Caco-2 cell 
permeability using atom-based bilinear indices. Afinidad, 71(566). doi: 
https://www.raco.cat/index.php/afinidad/article/view/278367/366141 
Cheng, C.-Y., Oh, H., Wang, T.-Y., Raghavan, S. R., & Tung, S.-H. (2014). Mixtures of lecithin and bile 
salt can form highly viscous wormlike micellar solutions in water. Langmuir, 30(34), 10221-
10230.  
Clark, D. E. (1999). Rapid calculation of polar molecular surface area and its application to the 
prediction of transport phenomena. 1. Prediction of intestinal absorption. Journal of 
pharmaceutical sciences, 88(8), 807-814.  
Coello, A., Meijide, F., Núñez, E. R., & Tato, J. V. (1996). Aggregation behavior of bile salts in aqueous 
solution. Journal of pharmaceutical sciences, 85(1), 9-15.  
de Castro, B., Gameiro, P., Guimarães, C., Lima, J. L., & Reis, S. (2001). Partition coefficients of β-
blockers in bile salt/lecithin micelles as a tool to assess the role of mixed micelles in 
gastrointestinal absorption. Biophysical chemistry, 90(1), 31-43.  
Dreiss, C. A. (2007). Wormlike micelles: where do we stand? Recent developments, linear rheology 
and scattering techniques. Soft Matter, 3(8), 956-970.  
Dressman, J., Amidon, G., & Fleisher, D. (1985). Absorption potential: estimating the fraction 
absorbed for orally administered compounds. Journal of pharmaceutical sciences, 74(5), 
588-589.  
Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate 
statistics. Journal of medicinal chemistry, 43(21), 3867-3877.  
Garcia-Alvarez-Coque, M., Torres-Lapasió, J., & Baeza-Baeza, J. (1997). Modelling of retention 
behaviour of solutes in micellar liquid chromatography. Journal of Chromatography A, 
780(1), 129-148.  
Grès, M.-C., Julian, B., Bourrié, M., Meunier, V., Roques, C., Berger, M., . . . Fabre, G. (1998). 
Correlation between oral drug absorption in humans, and apparent drug permeability in TC-
7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. 
Pharmaceutical research, 15(5), 726-733.  
Hou, T., Wang, J., Zhang, W., & Xu, X. (2007). ADME evaluation in drug discovery. 7. Prediction of 
oral absorption by correlation and classification. Journal of chemical information and 
modeling, 47(1), 208-218. doi: 10.1021/ci600343x 
https://pubchem.ncbi.nlm.nih.gov/. (December, 2014).  
Johnson, K. C., & Swindell, A. C. (1996). Guidance in the setting of drug particle size specifications to 
minimize variability in absorption. Pharmaceutical research, 13(12), 1795-1798.  
  
This article is protected by copyright. All rights reserved. 
Kansy, M., Senner, F., & Gubernator, K. (1998). Physicochemical high throughput screening: parallel 
artificial membrane permeation assay in the description of passive absorption processes. 
Journal of medicinal chemistry, 41(7), 1007-1010.  
Kawczak, P., Vander Heyden, Y., Nasal, A., Bączek, T., Drabczyñska, A., Kied‐Kononowicz, K., & 
Kaliszan, R. (2010). Micellar liquid chromatography for lipophilicity determination of new 
biologically active 1, 3‐purinodiones. Journal of separation science, 33(11), 1546-1557.  
Kennedy, T. (1997). Managing the drug discovery/development interface. Drug discovery today, 
2(10), 436-444.  
Khaledi, M. G. (1988). Hydrophobic selectivity in micellar and hydro-organic reversed-phase liquid 
chromatography. Analytical chemistry, 60(9), 876-887.  
Khaledi, M. G., Peuler, E., & Ngeh-Ngwainbi, J. (1987). Retention behavior of homologous series in 
reversed-phase liquid chromatography using micellar, hydro organic, and hybrid mobile 
phases. Analytical chemistry, 59(23), 2738-2747.  
Linnankoski, J., Mäkelä, J. M., Ranta, V.-P., Urtti, A., & Yliperttula, M. (2006). Computational 
prediction of oral drug absorption based on absorption rate constants in humans. Journal of 
medicinal chemistry, 49(12), 3674-3681.  
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational 
approaches to estimate solubility and permeability in drug discovery and development 
settings. Adv Drug Deliv Rev, 46(1-3), 3-26.  
Madenci, D., Salonen, A., Schurtenberger, P., Pedersen, J. S., & Egelhaaf, S. U. (2011). Simple model 
for the growth behaviour of mixed lecithin–bile salt micelles. Physical Chemistry Chemical 
Physics, 13(8), 3171-3178.  
Malik, N. A. (2016). Solubilization and Interaction Studies of Bile Salts with Surfactants and Drugs: a 
Review. Applied biochemistry and biotechnology, 179(2), 179-201.  
Marina, M., & Garcia, M. (2000). Micellar liquid chromatography. Encyclopedia of separation science. 
Level II. Methods and instrumentation.–Elsevier, 729-737.  
Mazer, N. A., Benedek, G. B., & Carey, M. C. (1980). Quasielastic light-scattering studies of aqueous 
biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions. Biochemistry, 
19(4), 601-615.  
Natalini, B., Sardella, R., Gioiello, A., Ianni, F., Di Michele, A., & Marinozzi, M. (2014). Determination 
of bile salt critical micellization concentration on the road to drug discovery. Journal of 
pharmaceutical and biomedical analysis, 87, 62-81.  
Newby, D., Freitas, A. A., & Ghafourian, T. (2015). Decision trees to characterise the roles of 
permeability and solubility on the prediction of oral absorption. European journal of 
medicinal chemistry, 90, 751-765. doi: 10.1016/j.ejmech.2014.12.006 
Norinder, U., Österberg, T., & Artursson, P. (1999). Theoretical calculation and prediction of 
intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. 
European journal of pharmaceutical sciences, 8(1), 49-56. doi: 10.1016/S0928-
0987(98)00059-1 
Norris, D., Leesman, G., Sinko, P., & Grass, G. (2000). Development of predictive pharmacokinetic 
simulation models for drug discovery. Journal of controlled release, 65(1), 55-62.  
Palm, K., Stenberg, P., Luthman, K., & Artursson, P. (1997). Polar molecular surface properties 
predict the intestinal absorption of drugs in humans. Pharmaceutical research, 14(5), 568-
571.  
Pramauro, E., Minero, C., Saini, G., Graglia, R., & Pelizzetti, E. (1988). Partition equilibria of phenols 
between water and anionic micelles: Correlation with the octanol/water system. Analytica 
chimica acta, 212, 171-180.  
Prentis, R., Lis, Y., & Walker, S. (1988). Pharmaceutical innovation by the seven UK‐owned 
pharmaceutical companies (1964‐1985). British journal of clinical pharmacology, 25(3), 387-
396.  
  
This article is protected by copyright. All rights reserved. 
Raevsky, O. A. (2004). Physicochemical descriptors in property-based drug design. Mini reviews in 
medicinal chemistry, 4(10), 1041-1052.  
Raevsky, O. A., Fetisov, V. I., Trepalina, E. P., McFarland, J. W., & Schaper, K. J. (2000). Quantitative 
Estimation of Drug Absorption in Humans for Passively Transported Compounds on the Basis 
of Their Physico‐chemical Parameters. Quantitative Structure‐Activity Relationships, 19(4), 
366-374. doi: 10.1002/1521-3838(200010)19:4<366::AID-QSAR366>3.0.CO;2-E 
Reis, S., Moutinho, C. G., Matos, C., de Castro, B., Gameiro, P., & Lima, J. L. (2004). Noninvasive 
methods to determine the critical micelle concentration of some bile acid salts. Analytical 
biochemistry, 334(1), 117-126.  
Ruiz-Angel, M., Carda-Broch, S., Torres-Lapasió, J. R., & García-Álvarez-Coque, M. (2009). Retention 
mechanisms in micellar liquid chromatography. Journal of Chromatography A, 1216(10), 
1798-1814.  
Ruiz‐Ángel, M. J., García‐Álvarez‐Coque, M. C., & Berthod, A. (2009). New insights and recent 
developments in micellar liquid chromatography. Separation & Purification Reviews, 38(1), 
45-96.  
Rutkowska, E., PajIk, K., & Jóźwiak, K. (2012). Lipophilicity methods of determination and its role in 
medicinal chemistry. Acta poloniae pharmaceutica, 70(1), 3-18.  
Schurtenberger, P., Scartazzini, R., & Luisi, P. (1989). Viscoelastic properties of polymerlike reverse 
micelles. Rheologica Acta, 28(5), 372-381.  
Scott, D. C., & Clymer, J. W. (2002). Estimation of Distribution Coefficients from the Partition 
Coefficient and pKa. Pharmaceutical technology, 30-40.  
Shchipunov, Y. A. (2001). Lecithin organogel: a micellar system with unique properties. Colloids and 
Surfaces A: Physicochemical and Engineering Aspects, 183, 541-554.  
Stenberg, P., Luthman, K., Ellens, H., Lee, C. P., Smith, P. L., Lago, A., . . . Artursson, P. (1999). 
Prediction of the intestinal absorption of endothelin receptor antagonists using three 
theoretical methods of increasing complexity. Pharmaceutical research, 16(10), 1520-1526.  
Varma, M. V., Sateesh, K., & Panchagnula, R. (2005). Functional role of P-glycoprotein in limiting 
intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein 
mediated efflux transport. Molecular pharmaceutics, 2(1), 12-21. doi: 10.1021/mp0499196 
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular 
properties that influence the oral bioavailability of drug candidates. Journal of medicinal 
chemistry, 45(12), 2615-2623. doi: 10.1021/jm020017n 
Venkatesh, S., & Lipper, R. A. (2000). Role of the development scientist in compound lead selection 
and optimization. Journal of pharmaceutical sciences, 89(2), 145-154.  
Walter, A., Vinson, P. K., Kaplun, A., & Talmon, Y. (1991). Intermediate structures in the cholate-
phosphatidylcholine vesicle-micelle transition. Biophysical journal, 60(6), 1315-1325.  
Waters, L. J., Shokry, D. S., & Parkes, G. (2016). Predicting human intestinal absorption in the 
presence of bile salt with micellar liquid chromatography. Biomedical Chromatography, 
30(10), 1618-1624. doi: 10.1002/bmc.3731 
Wiedmann, T. S., Liang, W., & Kamel, L. (2002). Solubilization of drugs by physiological mixtures of 
bile salts. Pharmaceutical research, 19(8), 1203-1208.  
Yan, A., Wang, Z., & Cai, Z. (2008). Prediction of human intestinal absorption by GA feature selection 
and support vector machine regression. International Journal of Molecular Sciences, 9(10), 
1961-1976. doi: 10.3390/ijms9101961 
Zhao, Y. H., Abraham, M. H., Le, J., Hersey, A., Luscombe, C. N., Beck, G., . . . Cooper, I. (2002). Rate-
limited steps of human oral absorption and QSAR studies. Pharmaceutical research, 19(10), 
1446-1457.  
 
  
  
This article is protected by copyright. All rights reserved. 
 
Figure 1: Chromatograms showing binding behaviour of ketoprofen in increasing 
concentrations of physiological micellar bile salts mixture as a mobile phase. (The dotted line 
is only used for visual guidance).  
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Figure 2: Schematic of the self-assembled structures formed by lecithin with, and without, 
bile salt in water (Cheng et al., 2014). 
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Figure 3: Residual plot for optimal logit HIA regression model. 
 
 
 
 
 
 
 
 
Figure 4: Partial regression plots of experimental logit HIA values against log Pmw and PSA. 
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Figure 5: Regression plot of predicted %HIA values against Literature %HIA. 
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Table 1:   Calculated log Pmw values (using experimental MLC data) and literature values of 
polar surface area (PSA) for the 18 model compounds (https://pubchem.ncbi.nlm.nih.gov/, 
December, 2014) 
 
Drug Log Pmw  PSA 
Acetaminophen 1.31 49.3 
Acetylsalicylic acid 1.74 63.6 
Caffeine 0.93 58.4 
Carbamazepine 2.39 46.3 
Cimetidine 1.97 88.89 
Diclofenac 2.94 49.3 
Fenoprofen 2.52 46.5 
Fluconazole 1.40 81.6 
Flurbiprofen 2.55 37.3 
Ibuprofen 1.52 37.3 
Ketoprofen 1.58 54.4 
Naproxen 2.37 46.5 
Nicotinic acid 1.55 50.2 
Phenylbutazone 2.15 40.6 
Salicylic acid 1.69 57.5 
Terbutaline 2.96 72.7 
Theophylline 1.02 69.3 
Zolmitriptan 2.30 57.4 
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Table 2: Experimental and predicted values for % HIA. 
Drug Expt. %HIA Reference Pred. %HIA 
Acetaminophen* 100 
(Castillo-Garit, Cañizares-
Carmenate, Marrero-Ponce, 
Abad, & Torrens, 2014) 
98 
Acetylsalicylic acid 82 (Castillo-Garit et al., 2014) 92 
Caffeine 99 (Yan, Wang, & Cai, 2008) 99 
Carbamazepine 84 
(Dressman, Amidon, & Fleisher, 
1985; Varma, Sateesh, & 
Panchagnula, 2005) 
87 
Cimetidine 68 
(Castillo-Garit et al., 2014; 
Linnankoski, Mäkelä, Ranta, 
Urtti, & Yliperttula, 2006) 
66 
Diclofenac 54 (Veber et al., 2002) 64 
Fenoprofen 85 (Hou, Wang, Zhang, & Xu, 2007) 83 
Fluconazole 94 
(Newby, Freitas, & Ghafourian, 
2015) 
90 
Flurbiprofen 92 (Raevsky, 2004) 88 
Ibuprofen* 98 (Newby et al., 2015) 99 
Ketoprofen 95 (Newby et al., 2015) 96 
Naproxen 94 (Castillo-Garit et al., 2014) 87 
Nicotinic acid 94 (Newby et al., 2015) 97 
Phenylbutazone 
94 
(Hou et al., 2007; Veber et al., 
2002) 94 
Salicylic acid* 99 (Raevsky, 2004) 95 
Terbutaline 25 (Grès et al., 1998) 34 
Theophylline 
98 
(Kansy, Senner, & Gubernator, 
1998) 98 
Zolmitriptan 92 (Newby et al., 2015) 82 
The asterisk (*) indicates the validation compounds. 
 
 
 
 
 
